PHARMA POSITIVE
Timeline
27 events since 2014Board
Capital
Filings
Financial
Establishments
2014201620182020202220242026
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed NBBabbreviated format · 2 days before the deadline
2025
Annual accounts 2024 filed PDFfull format · 20 days late
Registered in the Peppol Directory Reachable for e-invoices through 0208:0551980676
2024
Highest result from 2014 to 2025 net €318,322 ▲21.1% The operating result of €476,985 and the net result of €318,322 are both a record.
Annual accounts 2023 filed PDFfull format · 22 days late
2023
Annual accounts 2022 filed PDFfull format · 28 days late
1 manager resigning, 1 director reappointed resigns as manager · acts as permanent representative · reappointed as director · General meeting of 31-05-20239 points ▸
- General meeting of 31-05-2023
- The capital is divided into 1,000 shares
- resigns as manager
- acts as permanent representative
- reappointed as director, not named in the articles
- Discharge granted to
- The registered office is at Woluwe-Saint-Lambert (1200 Bruxelles), rue Théodore De Cuyper 165, boîte 51
- Power of attorney granted to
- Power of attorney granted to
- The deed holds 3 more points.
2022
Equity above €1m equity €1.0m ▲25.6% Equity rises from €814,227 to €1.0m.
Annual accounts 2021 filed PDFfull format · 18 days before the deadline
2021
Annual accounts 2020 filed PDFfull format
Annual accounts 2020 filed PDFmicro format · 26 days before the deadline
2020
Annual accounts 2019 filed PDFmicro format · 21 days late
2019
Liquidity more than 11 times current ratio 1.77 The current ratio rises from 0.15 to 1.77. Short-term debt falls from €877,580 to €391,399.
Equity above €500,000 equity €543,868 ▲100% With a profit in every financial year since 2014, equity grows to €543,868.
New manager appointed, resigned · acts as permanent representative · General meeting of 02-01-20194 points ▸
- General meeting of 02-01-2019
- resigns as manager
- appointed as manager
- acts as permanent representative
Annual accounts 2018 filed PDFmicro format · 20 days late
Merger: ARTHUR'S HEALTH & WELNESS takes over AVL PHARMACompany renamed from ARTHUR'S HEALTH & WELNESS to PHARMA POSITIVE · resigns as manager · acts as permanent representative · General meeting of 07-01-20198 points ▸
- General meeting of 07-01-2019
- Operation treated as a merger by absorption
- The company holds all the shares of AVL PHARMA
- The operation takes effect in the accounts on 01-01-2019
- resigns as manager
- acts as permanent representative
- Name change, PHARMA POSITIVE
- Article 1 of the articles of association amended
- The deed holds 4 more points.
2018
Weakest financial year net €1,835 ▼91.5% The net result drops to €1,835, the lowest from 2014 to 2025. It recovers the following year.
Merger proposal: ARTHUR'S HEALTH & WELNESS takes over AVL PHARMAThe company holds all the shares of AVL PHARMA2 points ▸
- The company holds all the shares of AVL PHARMA
- Merger by absorption
- The deed holds 4 more points.
Annual accounts 2017 filed PDFfull format · 23 days late
2017
Annual accounts 2016 filed PDFfull format · 24 days late
2016
Annual accounts 2015 filed PDFfull format · 22 days late
2015
Equity above €200,000 equity €234,695 ▲125% With a profit in every financial year since 2014, equity grows to €234,695.
Annual accounts 2014 filed PDFfull format · 27 days late
2014
acts as permanent representativeBoard meeting of 30-06-20142 points ▸
- Board meeting of 30-06-2014
- acts as permanent representative
IncorporationFounding capital of €100,000, 1,000 shares · Founded by (comparant) and (comparante) · (manager) and (manager) appointed · published on 09-05-20149 points ▸
- Founded by
- Founded by
- The founding capital is €100,000, divided into 1,000 shares
- holds 500 shares
- holds 500 shares
- appointed as manager
- appointed as manager
- Power of attorney granted to
- Power of attorney granted to
- The deed holds 3 more points.
First establishment ARTHUR'S HEALTH & WELNESS, Théodore De Cuyperstraat 165, Woluwe-Saint-Lambert
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
PHARMA POSITIVE was incorporated on 7 May 2014 by two private individuals, with a starting capital of €100,000.12 In 2019 the company absorbed AVL PHARMA by merger.3 Since 2019, has served as manager.4 Total assets fell from €2.6m in 2019 to €2.1m in 2025 and headcount from 3 to 4.4 full-time equivalents.5
Mentions of companies taken over
AVL PHARMA, the company PHARMA POSITIVE took over in the merger published in the Belgian Official Gazette on 05-02-2019, is named in 8 deeds.